Bullying and Long-Term Mental Health: Depression, Suicide Risk, PTSD, and Developmental Trajectories — A Clinical Review

Bullying — defined as repeated, intentional aggressive behavior involving a power imbalance between perpetrator and target — has transitioned from a dismissed schoolyard phenomenon to a recognized form of developmental adversity with measurable, long-term psychiatric consequences. The World Health Organization classifies peer victimization as a significant public health concern, and accumulating longitudinal evidence demonstrates that childhood and adolescent bullying victimization confers risk for psychopathology that persists well into adulthood, independent of pre-existing vulnerabilities.

The scope of exposure is substantial. The National Center for Education Statistics (2022) reports that approximately 22% of U.S. students aged 12–18 report being bullied at school, while the WHO Health Behaviour in School-aged Children (HBSC) survey estimates that roughly 11% of adolescents across 45 countries experience chronic bullying victimization. Cyberbullying adds a distinct dimension: the Pew Research Center (2022) found that 46% of U.S. teens have experienced at least one form of online harassment, with 15% describing severe or persistent cyberbullying.

What distinguishes bullying from other forms of childhood adversity — and what makes it clinically complex — is its intersection with normative developmental processes. Bullying typically occurs during critical windows for identity formation, social-cognitive maturation, and neurobiological development. The psychiatric sequelae are correspondingly broad: major depressive disorder (MDD), post-traumatic stress disorder (PTSD), generalized anxiety disorder (GAD), social anxiety disorder, suicidal ideation and behavior, substance use disorders, and psychotic experiences have all been linked to bullying victimization in prospective cohort studies. This article examines the neurobiological mechanisms, epidemiological evidence, diagnostic considerations, treatment approaches, and prognostic factors that define this clinical domain.

Large-scale epidemiological studies have established bullying victimization as one of the most common adverse childhood experiences. The Adverse Childhood Experiences (ACE) framework, while not originally including peer victimization, has been expanded in subsequent research to incorporate bullying, which in many studies emerges as more prevalent than household-level adversities such as parental incarceration or sexual abuse.

Prevalence of Bullying Victimization

• Traditional bullying: Meta-analytic estimates place global prevalence at approximately 35% for involvement in any bullying role (victim, perpetrator, or bully-victim), with roughly 15–20% of students reporting chronic victimization across multiple time points (Modecki et al., 2014).
• Cyberbullying: A meta-analysis by Zhu et al. (2021) across 159 studies estimated a pooled cyberbullying victimization prevalence of approximately 15%, though rates vary widely by definition, measurement period, and platform assessed.
• Bully-victims: Approximately 5–8% of youth occupy the dual role of bully-victim, a subgroup that consistently demonstrates the highest psychiatric morbidity across studies.

Dose-Response Relationships

Evidence strongly supports a dose-response relationship between bullying exposure and psychiatric outcomes. The landmark Great Smoky Mountains Study (Copeland et al., 2013) — a prospective, population-based longitudinal study — demonstrated that cumulative exposure to peer victimization in childhood predicted elevated rates of depression, anxiety disorders, and suicidality in young adulthood in a graded fashion: more frequent or prolonged victimization yielded progressively higher odds ratios. Specifically, children who were frequently bullied had an adjusted odds ratio of 4.8 for depressive disorders and 3.4 for anxiety disorders in young adulthood, while those bullied at only one assessment wave showed more modest elevations (OR 1.7–2.1).

The Avon Longitudinal Study of Parents and Children (ALSPAC) and the E-Risk Longitudinal Twin Study — both UK-based prospective cohorts — corroborate these findings, showing that victimization at ages 8–10 predicts depression, self-harm, and psychotic experiences at age 18, even after controlling for family-level confounders, genetic liability, and pre-existing emotional/behavioral difficulties.

Bullying victimization exerts its long-term psychiatric effects through identifiable neurobiological mechanisms that parallel — and in some cases are indistinguishable from — those observed in other forms of childhood adversity. The developing brain's heightened plasticity during childhood and adolescence makes it particularly vulnerable to stress-mediated alterations in neural circuitry, neuroendocrine function, and neuroinflammation.

Hypothalamic-Pituitary-Adrenal (HPA) Axis Dysregulation

Chronic social stress from bullying activates the HPA axis, leading initially to cortisol hypersecretion and subsequently — with chronic or severe exposure — to a blunted cortisol response pattern (hypocortisolism). This trajectory mirrors findings in other forms of childhood maltreatment. Vaillancourt et al. (2008, 2011) demonstrated in longitudinal studies that bullied children exhibit flattened diurnal cortisol slopes and blunted cortisol reactivity to social stressors, patterns associated with increased vulnerability to depression, PTSD, and externalizing disorders. The shift from hyper- to hypo-cortisolism appears to be a marker of allostatic overload — the point at which stress-response systems become dysregulated rather than protective.

Brain Structural and Functional Changes

Neuroimaging research has identified several structural and functional alterations associated with peer victimization:

• Amygdala hyperreactivity: Bullied youth show heightened amygdala responses to social threat cues (e.g., angry or contemptuous facial expressions), reflecting sensitization of threat-detection circuits. This mirrors patterns observed in anxiety disorders and PTSD.
• Prefrontal cortex (PFC) thinning: The IMAGEN consortium study and other longitudinal neuroimaging studies have demonstrated that peer victimization is associated with reduced gray matter volume and cortical thinning in the ventromedial and dorsolateral PFC — regions critical for emotion regulation, cognitive reappraisal, and social decision-making.
• Altered ventral striatum function: Bullying victimization has been associated with blunted ventral striatal response to reward, a neural signature of anhedonia and a putative mechanism linking bullying to depressive vulnerability.
• Hippocampal volume reductions: While more robustly documented in childhood maltreatment broadly, emerging evidence suggests peer victimization contributes to hippocampal volume reductions, particularly when exposure is chronic, with implications for memory consolidation and contextual fear processing.

Neurotransmitter and Neuroimmune Alterations

Bullying victimization has been associated with alterations in multiple neurotransmitter systems:

• Serotonin (5-HT) system: Gene-environment interaction studies (e.g., involving the 5-HTTLPR polymorphism) initially suggested that the short allele moderated the impact of bullying on depression risk, though subsequent meta-analyses have yielded mixed results. What remains clear is that chronic social stress affects serotonergic signaling, tryptophan metabolism, and 5-HT1A receptor sensitivity.
• Dopamine system: Social defeat paradigms in animal models — considered the best analog for bullying — produce robust changes in mesolimbic dopamine signaling, including reduced D2 receptor availability in the ventral striatum and altered dopamine release in the nucleus accumbens. These changes are associated with social avoidance, anhedonia, and increased sensitivity to subsequent stressors.
• Neuroinflammation: Bullied youth demonstrate elevated peripheral inflammatory markers, including C-reactive protein (CRP) and interleukin-6 (IL-6). The E-Risk Twin Study (Takizawa et al., 2015) showed that bullying victimization in childhood predicted elevated CRP levels in adulthood, even after controlling for BMI, smoking, and socioeconomic status. Neuroinflammation is increasingly recognized as a transdiagnostic mechanism linking early adversity to depression, psychosis, and accelerated cellular aging.

Epigenetic Modifications

Peer victimization has been associated with epigenetic changes, including altered DNA methylation of genes involved in HPA axis regulation (e.g., NR3C1, encoding the glucocorticoid receptor) and serotonin transport (SLC6A4). The E-Risk Twin Study has provided particularly compelling evidence: within monozygotic twin pairs discordant for bullying exposure, the bullied twin showed differential methylation patterns at stress-related gene loci, establishing that these epigenetic changes are not attributable to shared genetic background. Additionally, bullied children have been found to have shorter telomeres — a marker of accelerated biological aging — suggesting that peer victimization literally ages the body at a cellular level.

Major Depressive Disorder

Depression is the most consistently and robustly documented psychiatric outcome of bullying victimization. A comprehensive meta-analysis by Ttofi et al. (2011) examining 28 longitudinal studies found that bullying victimization approximately doubled the risk of subsequent depression (pooled OR ≈ 2.0), with effects persisting after adjustment for baseline depression and multiple confounders. The Great Smoky Mountains Study reported even stronger effects for frequent victimization (OR = 4.8 for any depressive disorder by young adulthood). Critically, these are conservative estimates, as studies controlling for genetic confounding (e.g., twin designs) still demonstrate significant effects, suggesting causal or quasi-causal pathways rather than mere confounding by pre-existing vulnerability.

The phenomenology of bullying-related depression often involves prominent features of shame, social withdrawal, negative self-referential processing ("I am defective," "I deserve this"), and interpersonal sensitivity — features that overlap with rejection-sensitivity phenotypes and may respond differently to treatment than depression arising from other etiologies.

Post-Traumatic Stress Disorder

The relationship between bullying and PTSD is clinically significant but diagnostically nuanced. Under DSM-5-TR criteria, PTSD requires exposure to actual or threatened death, serious injury, or sexual violence (Criterion A). Most bullying does not meet this threshold, which creates a diagnostic gap: many bullying victims present with a full post-traumatic symptom profile — intrusive memories, avoidance, negative cognitive alterations, and hyperarousal — but technically do not qualify for a PTSD diagnosis.

Studies using broader trauma definitions report PTSD prevalence rates of approximately 20–30% among severely bullied youth. Idsoe et al. (2012) found that 27.6% of bullied Norwegian adolescents met clinical thresholds for PTSD symptomatology. The ICD-11 diagnostic system, with its narrower PTSD criteria focused on re-experiencing, avoidance, and sense of current threat, may actually capture bullying-related PTSD more effectively than the broader DSM-5-TR construct. Additionally, ICD-11 Complex PTSD — which adds disturbances in self-organization (affect dysregulation, negative self-concept, relational difficulties) — may be particularly applicable to chronic bullying victims, though this remains an active area of research.

Suicidal Ideation and Behavior

The association between bullying and suicidality is robust and dose-dependent. A meta-analysis by Holt et al. (2015) across 47 studies found that bullying victimization was significantly associated with suicidal ideation (OR = 2.55) and suicide attempts (OR = 2.97). The bully-victim subgroup showed the highest risk, with odds ratios for suicide attempts exceeding 4.0 in several studies. These associations hold after controlling for depression, suggesting both direct and depression-mediated pathways to suicidal behavior.

The interpersonal theory of suicide (Joiner, 2005) provides a particularly relevant framework: bullying directly induces both thwarted belongingness (social exclusion, rejection) and perceived burdensomeness (beliefs that one is a burden on others), the two proximal risk factors Joiner identified as jointly necessary for suicidal desire. Chronic physical victimization may additionally contribute to acquired capability for suicide through habituation to pain and fear.

Other Psychiatric Outcomes

• Social anxiety disorder: Bullying victimization is one of the strongest environmental predictors of social anxiety, with prospective studies reporting ORs of 2.0–4.0. The pathway likely involves classical conditioning of social situations with threat, reinforced by avoidance.
• Psychotic experiences: The E-Risk and ALSPAC studies both demonstrated that bullying victimization doubles the risk of subclinical psychotic experiences (e.g., hearing voices, paranoid ideation) in adolescence and early adulthood. The proposed mechanism involves social defeat-driven dopaminergic sensitization.
• Substance use disorders: Victimized youth show elevated rates of alcohol and cannabis use disorder, likely reflecting self-medication pathways (OR ≈ 1.5–2.0).
• Eating disorders: Bullying — particularly weight-based teasing — predicts binge eating and bulimic behaviors, with ORs in the range of 2.0–3.5.

Clinicians evaluating patients with a history of significant bullying face several diagnostic challenges that deserve careful attention.

The PTSD Criterion A Problem

As noted, DSM-5-TR's narrow Criterion A excludes most bullying, creating a scenario where patients with clinically significant post-traumatic symptoms go undiagnosed or receive less specific diagnoses. Clinicians should be aware that Adjustment Disorders with mixed emotional features or Other Specified Trauma- and Stressor-Related Disorder may serve as appropriate diagnostic alternatives. However, these categories carry less clinical weight and may limit access to trauma-focused treatments. ICD-11's Complex PTSD, which does not require the same Criterion A threshold and explicitly addresses prolonged relational trauma, may be more clinically useful.

Differentiating Bullying-Related Presentations from Pre-Existing Conditions

A central diagnostic challenge is determining whether psychiatric symptoms preceded, were exacerbated by, or were caused by bullying victimization. Children with pre-existing ADHD, autism spectrum disorder, learning disabilities, or internalizing disorders are disproportionately targeted — prevalence of bullying victimization among autistic youth approaches 44–77% depending on the study. Clinicians must assess:

• Temporal sequence: Did symptoms demonstrably worsen following the onset of bullying, or were they present at similar severity beforehand?
• Symptom content: Are symptoms thematically linked to the bullying experience (e.g., intrusive memories of specific events, avoidance of school environments, shame-based self-beliefs)?
• Course pattern: Bullying-related symptoms often show temporal patterns linked to school attendance (weekday exacerbations, holiday improvement), which may help disambiguate etiology.

Underrecognition of Bullying as a Clinical Factor

A significant clinical pitfall is the failure to assess for bullying history systematically. Many clinicians assess for household-level adverse childhood experiences (abuse, neglect, domestic violence) but do not routinely inquire about peer victimization. Given the established evidence base, bullying history should be a standard component of psychosocial assessment for any youth or adult presenting with depression, anxiety, PTSD symptoms, social withdrawal, or school/work avoidance.

Cyberbullying-Specific Considerations

Cyberbullying introduces diagnostic complexity because the stressor is omnipresent — victims cannot escape by leaving the physical environment. This 24/7 exposure pattern more closely approximates chronic environmental threat than episodic trauma, which may shift the clinical presentation toward hypervigilance, sleep disruption, avoidance of digital environments (which are increasingly essential for social functioning), and a pervasive sense of unsafety. Clinicians should assess the mode, frequency, public visibility, and anonymity of cyberbullying, as each dimension affects clinical severity.

One of the most clinically significant findings in the bullying literature is that psychiatric effects are not limited to the period of active victimization. Multiple prospective longitudinal studies have demonstrated enduring effects into adulthood.

Evidence from Landmark Longitudinal Studies

The British National Child Development Study (1958 birth cohort), analyzed by Takizawa et al. (2014), provided some of the most striking evidence: individuals who were bullied at ages 7 and 11 had significantly elevated rates of depression, anxiety, and suicidality at age 50 — nearly four decades after the bullying occurred. The effect sizes were smaller than for proximal outcomes but remained statistically and clinically significant after extensive covariate adjustment (OR for depression at age 50 ≈ 1.5). These individuals also had lower educational attainment, lower income, higher unemployment, and fewer close relationships, suggesting bullying impacts extend beyond psychiatric diagnosis into broad psychosocial functioning.

The Great Smoky Mountains Study (Copeland et al., 2013) showed that among the three bullying roles, bully-victims had the worst adult outcomes, including the highest rates of depressive disorders (OR = 4.8), panic disorder (OR = 14.5), and suicidality. Pure victims had intermediate risk, while pure bullies had elevated rates of antisocial personality disorder but not internalizing disorders.

Developmental Cascades

Bullying sets in motion developmental cascades — chains of progressive consequences in which initial effects in one domain propagate into others:

• Academic cascade: Victimization → school avoidance → academic underperformance → reduced educational attainment → lower occupational status
• Social cascade: Victimization → social withdrawal → impaired social skill development → loneliness → depression
• Neurobiological cascade: Victimization → HPA axis dysregulation → neuroinflammation → accelerated biological aging → increased vulnerability to physical and psychiatric morbidity
• Cognitive cascade: Victimization → hostile attribution bias → social hypervigilance → relationship difficulties → re-victimization

These cascades explain why brief interventions targeting only the acute bullying episode are insufficient. Treatment must address the downstream consequences across multiple domains.

Sensitive Periods

Emerging evidence suggests that the timing of bullying exposure matters for outcome trajectory. Victimization during early adolescence (ages 11–14) — a period of heightened social-evaluative sensitivity, prefrontal cortical remodeling, and identity consolidation — may have particularly pronounced effects on self-concept and social functioning. However, this research is still evolving, and no definitive sensitive-period model has been established.

Treatment for bullying-related psychiatric conditions draws from the broader evidence base for depression, PTSD, and anxiety disorders, but with adaptations targeting the specific mechanisms activated by peer victimization. There is a notable gap in the literature: very few randomized controlled trials have specifically examined treatment outcomes for bullying-related psychopathology as a distinct category. Most evidence is extrapolated from broader treatment literature, supplemented by targeted intervention studies.

Cognitive-Behavioral Therapy (CBT)

CBT is the most extensively studied psychotherapy for bullying-related depression and anxiety. Standard CBT components — cognitive restructuring, behavioral activation, exposure — are augmented by social-skills training, assertiveness training, and schema-level work targeting core beliefs of defectiveness and unlovability that are frequently instilled by chronic victimization.

For depression in youth, CBT demonstrates response rates of approximately 55–65% and remission rates of 35–45%, with a number needed to treat (NNT) of approximately 4–6 compared to waitlist or treatment as usual. The Treatment for Adolescents with Depression Study (TADS) demonstrated that the combination of CBT and fluoxetine yielded the highest response rate (71%) compared to CBT alone (43%), fluoxetine alone (61%), or placebo (35%). While TADS was not specific to bullying-related depression, its findings inform treatment of this population.

Trauma-Focused CBT (TF-CBT)

For bullying victims presenting with post-traumatic symptoms, Trauma-Focused CBT (TF-CBT) — the gold-standard treatment for childhood PTSD — is increasingly applied, even when formal PTSD diagnostic criteria are not met. TF-CBT includes psychoeducation, relaxation skills, affect modulation, cognitive processing, trauma narrative development, and in vivo mastery of trauma reminders. Response rates for PTSD in youth range from 70–80%, with NNT of approximately 3–4 compared to supportive therapy. The Cohen, Mannarino, and Deblinger (2006) treatment manual provides the foundational framework, though adaptation for bullying-specific presentations (which often involve ongoing exposure risk and identity-level damage) is recommended.

EMDR (Eye Movement Desensitization and Reprocessing)

EMDR has a growing evidence base for childhood trauma, including bullying-specific applications. A randomized controlled trial by de Roos et al. (2017) comparing EMDR, CBT, and waitlist for children with PTSD symptoms found that both active treatments produced large effect sizes (Cohen's d > 1.5) with no significant difference between them. Small studies specifically targeting bullying-related distress with EMDR have shown promising results, but the evidence base remains limited compared to CBT and TF-CBT.

Pharmacotherapy

No medications are specifically indicated for "bullying-related" psychiatric conditions. Pharmacotherapy targets the resulting diagnoses:

• SSRIs for depression: Fluoxetine and escitalopram are FDA-approved for adolescent MDD. The Bridge meta-analysis (2007) found an NNT of approximately 10 for antidepressant response in pediatric depression, with a number needed to harm (NNH) for suicidal ideation/behavior of approximately 112, supporting a favorable risk-benefit ratio when monitored appropriately.
• SSRIs for PTSD: Sertraline and paroxetine have the strongest evidence for adult PTSD (NNT ≈ 5–8), but evidence in pediatric PTSD is weaker, and psychotherapy is generally preferred as first-line treatment.
• Prazosin for nightmares: For bullying victims with prominent re-experiencing symptoms including nightmares, prazosin (an alpha-1 adrenergic antagonist) has shown benefit in adult PTSD (though the RASKIND VA trial results were mixed), with limited pediatric data.

Anti-Bullying Interventions as Primary Prevention

The Olweus Bullying Prevention Program (OBPP) — the most extensively studied school-based prevention program — has demonstrated reductions in bullying perpetration and victimization of approximately 20–70% across studies, though effect sizes vary substantially by implementation context. A large meta-analysis by Ttofi and Farrington (2011) across 44 program evaluations found an average 20–23% reduction in bullying perpetration and a 17–20% reduction in victimization. Programs that are more intensive, longer-duration, and include parent and teacher components show larger effects. The KiVa program from Finland has shown similar or slightly superior effects in rigorous RCTs.

Understanding which bullied youth are most likely to develop chronic psychiatric conditions — and which demonstrate resilience — is critical for clinical risk stratification and resource allocation.

Factors Associated with Poorer Outcomes

• Chronicity and severity of victimization: The single strongest predictor of poor outcome. Chronic, multi-year bullying produces substantially worse outcomes than isolated incidents.
• Bully-victim status: Youth who are both perpetrators and victims consistently show the highest rates of psychiatric morbidity, including depression, PTSD, conduct problems, and suicidality.
• Multiple victimization types: Youth experiencing both physical and relational bullying, or both in-person and cyberbullying (poly-victimization), have worse outcomes than those experiencing a single modality.
• Pre-existing psychiatric vulnerability: Youth with baseline internalizing symptoms, neurodevelopmental conditions (ADHD, ASD), or family psychiatric history show steeper symptom trajectories following victimization.
• Low social support: Absence of supportive peer relationships, poor parent-child communication, and lack of teacher awareness/intervention are among the most potent moderators of outcome.
• Maladaptive coping: Self-blame, rumination, and avoidance coping predict worse psychiatric outcomes; active coping and help-seeking predict better outcomes.
• Genetic factors: Preliminary evidence suggests that variants in genes involved in serotonin transport (5-HTTLPR), HPA axis regulation (FKBP5), and dopamine signaling (COMT) moderate the psychiatric impact of peer victimization, though gene-environment interaction findings remain inconsistent and require replication.

Protective Factors and Resilience

• One supportive adult: Having even a single supportive relationship with a parent, teacher, or other adult substantially buffers the psychiatric impact of bullying. This is one of the most consistently replicated resilience factors.
• High-quality friendships: Having at least one close, reciprocal friendship reduces the impact of victimization on depression and anxiety.
• School climate: Schools with clear anti-bullying policies, warm teacher-student relationships, and cultures that do not normalize aggression have lower rates of bullying-related psychopathology.
• Self-efficacy and internal locus of control: Youth who attribute the bullying to the perpetrator's behavior rather than their own characteristics show better outcomes.
• Early intervention: Rapid identification and clinical intervention following the onset of bullying-related symptoms is associated with better prognosis.

Bullying-related psychiatric conditions rarely present in isolation. Comorbidity is the rule rather than the exception, and clinicians should expect and assess for multiple concurrent conditions.

Prevalence of Comorbidity

Among bullied youth who develop a diagnosable psychiatric condition:

• Depression + anxiety comorbidity: Approximately 50–60% of bullied youth with MDD also meet criteria for at least one anxiety disorder, compared to approximately 25–30% base rate comorbidity in non-bullied depressed youth.
• Depression + PTSD: Among bullied youth with post-traumatic symptoms, comorbid depressive disorder is present in approximately 40–50% of cases.
• Suicidal ideation + depression + substance use: This triad is particularly common in the bully-victim subgroup and represents a high-risk configuration requiring integrated assessment.
• ADHD/ASD + bullying-related internalizing disorders: Given the elevated victimization rates among neurodivergent youth (44–77% for ASD), this comorbidity pattern is extremely common and complicates both assessment and treatment. The pre-existing social-communication difficulties in ASD, for example, may make standard social-skills components of CBT less effective without adaptation.

Clinical Implications of Comorbidity

High comorbidity affects treatment planning in several ways. First, treatment must be sequenced or integrated to address multiple conditions simultaneously — treating depression without addressing PTSD symptoms, for example, often yields incomplete or unstable response. Second, comorbidity generally predicts slower treatment response and higher relapse rates, requiring longer treatment courses and more assertive follow-up. Third, the presence of substance use may preclude certain pharmacological interventions and complicates risk assessment for suicidality.

Emerging transdiagnostic approaches — such as the Unified Protocol for Transdiagnostic Treatment of Emotional Disorders in Adolescents (UP-A) — may be particularly well-suited for bullying-related presentations because they target shared underlying mechanisms (emotion dysregulation, avoidance, negative self-appraisal) rather than individual diagnoses. Preliminary data suggest efficacy comparable to diagnosis-specific protocols, with the advantage of addressing the full spectrum of bullying-related psychopathology within a single framework.

Cyberbullying warrants separate clinical consideration because it introduces features not present in traditional peer victimization. While the overall effect sizes for cyberbullying on mental health outcomes are similar to those for traditional bullying (meta-analytic effect sizes for depression: r ≈ 0.20–0.25), several unique characteristics amplify its potential for harm.

Unique Features of Cyberbullying

• Permanence and publicness: Digital content can be screenshotted, shared, and amplified indefinitely, extending the duration of victimization and increasing the audience of humiliation.
• Inescapability: Unlike school-based bullying, cyberbullying penetrates the home environment, disrupting the sense of safety in all settings and impairing sleep (due to evening/nighttime exposure).
• Anonymity: Anonymous perpetration increases the victim's sense of helplessness and paranoia, as threat cannot be localized to a specific individual.
• Rapid escalation: Online content can go viral, transforming a local conflict into a mass humiliation event within hours.

Mental Health Outcomes Specific to Cyberbullying

A meta-analysis by Kowalski et al. (2014) found that cyberbullying victimization was associated with depression (r = 0.24), anxiety (r = 0.22), and suicidal ideation (r = 0.18). Emerging evidence suggests that cyberbullying may have a particularly strong association with non-suicidal self-injury (NSSI), potentially because the public nature of online humiliation intensifies shame — a core emotional driver of NSSI.

Clinically, cyberbullying victims often present with prominent sleep disturbance (related to nighttime phone checking/anxiety), social media avoidance that paradoxically increases social isolation, and a sense of contamination or permanent damage to their social identity. These features may require targeted intervention, including digital safety planning, behavioral experiments around social media use, and cognitive processing of shame-related beliefs.

Despite substantial progress, the field faces several important limitations and active research questions.

Causality vs. Confounding

While prospective longitudinal studies and genetically informed designs (twin studies, sibling comparisons) provide strong evidence for causal or quasi-causal effects of bullying on mental health, residual confounding remains a concern. Shared genetic and environmental factors may partially account for the association between victimization and psychiatric outcomes. The E-Risk Twin Study's within-twin analyses — which demonstrate effects of bullying after controlling for shared genetic and family-level environmental confounders — provide the strongest evidence for causal effects, but cannot eliminate all sources of confounding.

Measurement Heterogeneity

A persistent challenge is the enormous variability in how bullying is measured across studies — self-report vs. peer-report vs. teacher-report, single-item vs. multi-item scales, different recall periods, and varying definitions of what constitutes bullying. This heterogeneity inflates variability in prevalence estimates and effect sizes, making precise quantification difficult.

Treatment Specificity

As noted, there are very few treatment trials specifically designed for bullying-related psychopathology. The field relies heavily on extrapolation from the broader depression, PTSD, and anxiety treatment literatures. RCTs targeting bullying-specific mechanisms — such as shame processing, interpersonal sensitivity, and social identity repair — are needed to determine whether adapted or novel treatments outperform standard protocols.

Emerging Research Directions

• Neuroimaging studies tracking brain development in bullied vs. non-bullied youth across adolescence, to identify mediating neural changes in real time.
• Digital phenotyping: Using smartphone sensor data (social media activity, sleep patterns, location data) to detect cyberbullying exposure and its psychiatric effects in ecologically valid settings.
• Inflammatory biomarkers as treatment targets: Given the evidence for neuroinflammation, trials examining anti-inflammatory adjunctive treatments (omega-3 fatty acids, minocycline) in bullying-related depression are warranted but not yet conducted.
• Precision prevention: Using genetic, temperamental, and environmental risk profiles to identify which children are most vulnerable to bullying-related psychopathology, enabling targeted early intervention before psychiatric conditions develop.
• Long-term follow-up of bystanders: Emerging evidence suggests that witnessing bullying also carries psychiatric risk, broadening the scope of affected individuals beyond direct victims.

Bullying victimization is a common, potent, and often underrecognized form of developmental adversity that confers substantial and enduring risk for depression, PTSD, suicidality, anxiety disorders, psychotic experiences, and broad psychosocial impairment. The evidence base supporting these associations is robust, drawing from multiple prospective longitudinal cohorts, genetically informed designs, and neurobiological investigations.

Key Clinical Recommendations

• Routine assessment: All mental health evaluations of children, adolescents, and adults should include systematic inquiry about peer victimization history, including cyberbullying.
• Diagnostic flexibility: Clinicians should consider PTSD-spectrum diagnoses for bullying-related post-traumatic presentations even when DSM-5-TR Criterion A is not formally met. ICD-11 Complex PTSD may be particularly applicable.
• Multimodal treatment: TF-CBT or adapted CBT is recommended as first-line treatment for bullying-related PTSD and depressive symptoms. SSRIs should be considered as adjunctive treatment for moderate-to-severe depression, with appropriate monitoring per FDA black box guidelines for pediatric populations.
• Address the environment: Treatment of the individual is insufficient if the bullying is ongoing. Clinicians should advocate for school-based intervention, safety planning, and environmental modification alongside psychiatric treatment.
• Screen for comorbidity: Given the high rates of co-occurring conditions, clinicians should assess for the full range of potential diagnoses, including substance use, NSSI, eating disorders, and psychotic experiences.
• Long-term follow-up: Given the evidence for effects persisting decades after exposure, clinicians should communicate to patients and families that periodic monitoring and booster treatment sessions may be needed, particularly during subsequent periods of social stress.